The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,292,379 in first-year total cost, median $789,853.
Most frequent study sections
- Special Emphasis Panel[ZCA1 PCRB-D (M1)]8
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR3
- CASE WESTERN RESERVE UNIVERSITY1
- FRED HUTCHINSON CANCER CENTER1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
- UT SOUTHWESTERN MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer2U01CA152662-11 | DEPPEN, STEPHENGROGAN, ERIC L | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $853,805 | ZCA1 |
| 2022 | Fred Hutchinson Breast Cancer Clinical Validation Center2U01CA152637-12 | LI, CHRISTOPHER IPARTRIDGE, SAVANNAH CORRINA | FRED HUTCHINSON CANCER CENTER, WA | $807,303 | ZCA1 |
| 2022 | Great Lakes New England Clinical Validation Center2U01CA086400-21 | BRESALIER, ROBERT SSYNGAL, SAPNA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $803,955 | ZCA1 |
| 2022 | Clinical Validation Center for Lung Cancer Early Detection1U01CA271888-01 | HANASH, SAMIR M | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $792,272 | ZCA1 |
| 2022 | Clinical Validation Center for Hepatocellular Carcinoma1U01CA271887-01 | KANWAL, FASIHAMARRERO, JORGE APARIKH, NEEHAR DILIPSINGAL, AMIT | UT SOUTHWESTERN MEDICAL CENTER, TX | $787,434 | ZCA1 |
| 2022 | Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation1U01CA271867-01 | BETTEGOWDA, CHETANCHAK, AMITABHMARKOWITZ, SANFORD D.SHAHEEN, NICHOLAS JWANI, SACHIN | CASE WESTERN RESERVE UNIVERSITY, OH | $781,052 | ZCA1 |
| 2022 | Clinical Validation Center for Early Detection of Pancreatic Cancer2U01CA200468-06 | MAITRA, ANIRBAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $737,111 | ZCA1 |
| 2022 | Blood-Based Testing for Advanced Adenoma1U01CA271884-01 | SCHOEN, ROBERT E.TOMASETTI, CRISTIAN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $729,447 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.